Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 41-50 of 181 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2003Selected CD34 blood cell allografts for older patients: low transplant-related mortality, graft failure and acute GvHDRoberts, M.; Dyson, P.; Rawling, C.; Thorp, D.; Rawling, T.; White, D.; Horvath, N.; Bardy, P.; Hui, C.; Dart, G.; To, L.; Hughes, T.
2002Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistantFrost, M.; Ferrao, P.; Hughes, T.; Ashman, L.
2004Oral versus intravenous ganciclovir for the prophylaxis of cytomegalovirus disease after allogeneic bone marrow transplantationSzer, J.; Durrant, S.; Schwarer, A.; Bradstock, K.; Gibson, J.; Arthur, C.; To, L.; Hughes, T.; Raunow, H.
2003Molecular monitoring of chronic myeloid leukemiaHughes, T.; Branford, S.
2001Mutation screening of the c-MYB negative regulatory domain in acute and chronic myeloid leukaemiaLutwyche, J.; Keough, R.; Hughes, T.; Gonda, T.
2003Comments on the Hammersmith policyHughes, T.
2000A new rare t(9;11)(p22;p15) in acute leukaemiaNicola, M.; Suttle, J.; Beerworth, J.; Dobrovic, A.; Hughes, T.; Moore, S.
2009Dasatinib in the Treatment of Chronic Myeloid Leukemia in Accelerated Phase After Imatinib Failure: The START A TrialApperley, J.; Cortes, J.; Kim, D.; Roy, L.; Roboz, G.; Rosti, G.; Bullorsky, E.; Abruzzese, E.; Hochhaus, A.; Heim, D.; De Souza, C.; Larson, R.; Lipton, J.; Khoury, J.; Kim, H.; Sillaber, C.; Hughes, T.; Erben, P.; Tornout, J.; Stone, R.
2009Dasatinib or high-dose Imatinib for chronic-phase chronic myeloid leukemia resistant to Imatinib at a dose of 400 to 600 milligrams daily. Two-year follow-up of a randomized phase 2 study (START-R)Kantarjian, H.; Pasquini, R.; Levy, V.; Jootar, S.; Holowiecki, J.; Hamerschlak, N.; Hughes, T.; Bleickardt, E.; Dejardin, D.; Cortes, J.; Shah, N.
2009Predicting the response of CML patients to tyrosine kinase inhibitor therapyWhite, D.; Hughes, T.